Palvella Therapeutics, Inc. · NASDAQ:PVLA

BVF PARTNERS L P/IL reported a 9.99% stake in Palvella Therapeutics, Inc. (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 14, 2025

BVF PARTNERS L P/IL reported a 9.99% stake in Palvella Therapeutics, Inc., 1,181,194 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).

Stake
9.99%
Shares
1,181,194
Intent
Passive
What changed
Stake changed
Filed together
10 holders

The filing in full

HolderStakeShares
BIOTECHNOLOGY VALUE FUND L P5.40%634,307
BVF I GP LLC5.40%634,307
BIOTECHNOLOGY VALUE FUND II LP4.00%474,740
BVF II GP LLC4.00%474,740
Biotechnology Value Trading Fund OS LP0.50%54,840
BVF Partners OS Ltd.0.50%54,840
BVF GP HOLDINGS LLC9.40%1,109,047
BVF PARTNERS L P/IL9.99%1,181,194
BVF INC/IL9.99%1,181,194
LAMPERT MARK N9.99%1,181,194

Source

View original at SEC

Related